NCT06248528 Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy. Status ACTIVE_NOT_RECRUITING Phase NA
NCT06247293 Surgical Resection Combined With Intraperitoneal Hyperthermic Chemotherapy Status UNKNOWN Phase N/A
NCT06244225 HAIC (Hepatic Artery Infusion Chemotherapy,HAIC)Plus Sintilimab and Donafenib in the First-line Treatment of Unresectable Hepatocellular Carcinoma Status RECRUITING Phase PHASE2
NCT06242470 A Study of MGC026 in Participants With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06239155 A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06236568 Impact of Graft Reconditioning With Hypothermic Machine Perfusion on HCC Recurrence After Liver Transplantation Status RECRUITING Phase NA
NCT06233981 Phase II Study of Moderate-dose Hypofractionated RT Combined With Tislelizumab for HCC With Diffuse Tumor Thrombosis Status COMPLETED Phase PHASE2
NCT06233708 Association Between Pre-op Non-Selective Beta-Blockers and Hepatocellular Carcinoma Recurrence Post-Liver Transplant Status COMPLETED Phase N/A
NCT06232759 TACE Combined With Tyrosine Kinase Inhibitors and Tislelizumab in Unresectable Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT06218511 A Phase I Trial of IMA970A Plus Montanide in Combination With Durvalumab (Anti-PD-L1) Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06218420 Evaluation of Stereotactic Body Radiotherapy as a Bridge Therapy for Hepatocellular Carcinoma Patients Enlisted for Liver Transplantation Status RECRUITING Phase PHASE2
NCT06217094 Study of NP-101 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Undergoing Y-90 Treatment Status WITHDRAWN Phase PHASE1
NCT06205706 BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06205472 Phase II Study of Adjuvant SIB Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCC. Status RECRUITING Phase PHASE2
NCT06204159 Lipiodol Deposition Using Endhole vs. Pressure-Modulated Delivery Status ACTIVE_NOT_RECRUITING Phase NA
NCT06201065 FOLFOX-HAIC Plus Lenvatinib and Toripalimab vs. FOLFOX-HAIC Plus Lenvatinib for Advanced Hepatocellular Carcinoma: a Randomized Controlled and Double-blind Trial Status RECRUITING Phase PHASE3
NCT06199297 Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma Status COMPLETED Phase N/A